Why Is Denali Therapeutics Inc. (NASDAQ: DNLI) Stock Down Today?

Denali Therapeutics Inc. (NASDAQ: DNLI) Summary

Denali Therapeutics Inc. (NASDAQ: DNLI) is trading down -2.04% at $19.72, reflecting a negative shift in investor sentiment today. The stock opened at $20.07 and has moved between $19.56 and $20.16 so far.

Trading volume is 2955959, which is 89% above its average, and the price action suggests selling interest.

Technically, DNLI on the NASDAQ is trading below its 50-day moving average of $23.64 and below its 200-day moving average of $20.95, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns DNLI a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +11.71% in 1 month ($22.03), +16.55% in 1 year ($22.98), and +80.40% in 5 years ($35.57).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.